glp-1 for long covid Inside the Study COVID, with lead scientist Dr Julia Vogel, Long Covid, MD Pod, Ep 61 New RECOVER-TLC trials won't enroll

Description

Eligibility for these medications is typically based on a case-by-case assessment, with general guidelines focusing on individuals with obesity (BMI of 30 or higher) or those overweight (BMI of 27 or higher) with at least one weight-related health condition

Again, we stress accelerated gastric emptying and functional dyspepsia or even normal gastric emptying with dyspepsia with identical symptoms in those patients with Gastroparesis can occur, and it is very important to document delayed gastric emptying because selective therapy with medications or new therapies and devices, such as promotility enhancing drugs or gastroesophageal stimulators (gastric-type pacemakers) may be indicated for one disorder and not the other